Search results for "Anxiolytic"

showing 10 items of 57 documents

Lavandula x intermedia—A Bastard Lavender or a Plant of Many Values? Part II. Biological Activities and Applications of Lavandin

2023

This review article is the second in a series aimed at providing an in-depth overview of Lavandula x intermedia (lavandin). In part I, the biology and chemistry of lavandin were addressed. In part II, the focus is on the functional properties of lavandin and its applications in industry and daily life. While reviewing the biological properties, only original research articles employing lavandin were considered. Lavandin essential oil has been found to have antioxidant and biocidal activity (antimicrobial, nematicidal, antiprotozoal, insecticidal, and allelopathic), as well as other potential therapeutic effects such as anxiolytic, neuroprotective, improving sleep quality, antithrombotic, an…

Lavandula hybridaantimicrobial activitybiocidal activityLavandula angustifoliaanxiolytic activityantioxidant activityLavandula x intermediaessential oilanti-inflammatoryMolecules
researchProduct

Housing conditions modulate the reinforcing properties of cocaine in adolescent mice that binge on fat

2017

Abstract Binge eating is a specific form of overeating characterized by intermittent, excessive eating. To date, several studies have addressed the effects that bingeing on fat has on the rewarding effects of drugs of abuse, but they have found contradictory and highly variable results. Housing conditions could modulate these results, as most studies employ isolated animals to measure the exact amount of food that is ingested. The aim of this study was to evaluate the effects of housing conditions on the response of mice to cocaine, modulated by bingeing on a high-fat diet during adolescence. After 40 days of binge-eating for 2 h, three days a week (PND 29–69), the reinforcing effects of a …

LeptinMalemedicine.medical_specialtyElevated plus mazemedicine.drug_classSpatial BehaviorExperimental and Cognitive PsychologyAnxietyDiet High-FatAnxiolyticCocaine-Related DisordersMiceRandom Allocation03 medical and health sciencesBehavioral Neurosciencechemistry.chemical_compound0302 clinical medicineCocaineDopamine Uptake InhibitorsRewardCorticosteroneInternal medicineConditioning PsychologicalAnimals Outbred StrainsmedicineAnimals0501 psychology and cognitive sciences050102 behavioral science & comparative psychologyBulimiaOvereatingBinge eatingLeptin05 social sciencesHousing AnimalConditioned place preferenceDisease Models AnimalEndocrinologySocial IsolationchemistryAnxietymedicine.symptomCorticosteronePsychology030217 neurology & neurosurgeryPhysiology & Behavior
researchProduct

The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients

2020

Background: Due to the inflammatory nature of multiple sclerosis (MS), interleukin 6 (IL-6) is high in blood levels, and it also increases the levels of anxiety related to functional disability. Epigallocatechin gallate (EGCG) decreases IL-6, which could be enhanced by the anti-inflammatory effect of high ketone bodies after administering coconut oil (both of which are an anxiolytic). Therefore, the aim of this study was to assess the impact of coconut oil and EGCG on the levels of IL-6, anxiety and functional disability in patients with MS. Methods: A pilot study was conducted for four months with 51 MS patients who were randomly divided into an intervention group and a control group. The …

Male0301 basic medicineTime FactorsMediterranean dietEmotionsPilot ProjectsEpigallocatechin gallateDiet Mediterraneanmultiple sclerosisGastroenterologyCatechinBody Mass IndexDisability Evaluationchemistry.chemical_compound0302 clinical medicineProspective Studiescoconut oilNutrition and DieteticsCoconut oilfood and beveragesMiddle AgedMultiple Sclerosis Chronic ProgressiveanxietyTreatment OutcomeAnxietyFemalemedicine.symptomlcsh:Nutrition. Foods and food supplyepigallocatechin gallatemedicine.medical_specialtyfood.ingredientmedicine.drug_classlcsh:TX341-641PlaceboAnxiolyticArticle03 medical and health sciencesMultiple Sclerosis Relapsing-RemittingfoodInternal medicinemedicineHumansExpanded Disability Status Scalebusiness.industryinterleukin-6Recovery of Function030104 developmental biologydisabilitychemistrySpainDietary SupplementsbusinessBody mass indexBiomarkers030217 neurology & neurosurgeryFood ScienceNutrients
researchProduct

Effects of acute administration of bupropion on behavior in the elevated plus-maze test by NMRI mice

2004

Bupropion attenuates some symptoms of nicotine abstinence, although its effects on anxiety are unclear. The present study investigates acute effects of bupropion (5, 10, 20 and 40 mg/kg) on anxiety as expressed in the elevated plus-maze test in male NMRI mice. Given the influence of locomotion in this test, effects of bupropion were also evaluated in an actimeter. Spontaneous motor activity remained significantly increased in mice treated with 10, 20 and 40 mg/kg of bupropion during the 60 min recorded. Results from the elevated plus-maze showed that 20 mg/kg increased total arm entries and 40 mg/kg increased total and open arm entries. Although the increase in the number of visits to the o…

MaleAcute effectsElevated plus mazemedicine.drug_classmedia_common.quotation_subjectAnxietyMotor ActivityPharmacologyAnxiolyticNicotineMicemedicineAnimalsBupropionBiological Psychiatrymedia_commonPharmacologyBupropionBehavior AnimalDose-Response Relationship DrugAbstinenceNmri miceAntidepressive Agents Second-GenerationAnxietymedicine.symptomPsychologymedicine.drugProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

The novelty-seeking phenotype modulates the long-lasting effects of intermittent ethanol administration during adolescence.

2013

The aim of the present study was to investigate if a novelty-seeking phenotype mediates the long-lasting consequences of intermittent EtOH intoxication during adolescence. The hole board test was employed to classify adolescent mice as High- or Low-Novelty Seekers. Subsequently, animals were administered ethanol (1.25 or 2.5 g/kg) on two consecutive days at 48-h intervals over a 14-day period. Anxiety levels - measured using the elevated plus maze- spontaneous motor activity and social interaction test were studied 3 weeks later. A different set of mice underwent the same procedure, but received only the 2.5 g/kg dose of ethanol. Three weeks later, in order to induce CPP, the same animals w…

MaleAginglcsh:MedicinePoison controlSocial SciencesAnxietyToxicologychemistry.chemical_compoundMiceBehavioral NeuroscienceCocaineMedicine and Health SciencesPsychologyPublic and Occupational Healthlcsh:ScienceHole-board testMultidisciplinaryAlcohol ConsumptionBehavior AnimalMDMAPhenotypeBehavioral PharmacologyAnxietymedicine.symptomBehavioral and Social Aspects of HealthReinforcement Psychologymedicine.drugResearch Articlemedicine.medical_specialtyElevated plus mazeAdolescentmedicine.drug_classN-Methyl-34-methylenedioxyamphetamineBiologyAnxiolyticInternal medicineMental Health and PsychiatrymedicineAnimalsHumansMaze LearningNutritionPharmacologyBehaviorEthanolEthanollcsh:RNovelty seekingBiology and Life SciencesDietEndocrinologychemistryExploratory Behaviorlcsh:QClinical MedicineNeurosciencePloS one
researchProduct

Diazepam has no beneficial effects on stress-induced behavioural and endocrine changes in male tree shrews.

2000

Abstract VAN KAMPEN, M., U. SCHMITT, C. HIEMKE AND E. FUCHS. Diazepam has no beneficial effects on stress-induced behavioural and endocrine changes in male tree shrews. PHARMACOL BIOCHEM BEHAV 65 (3) 539–546, 2000.—The present study evaluated the effect of subchronic oral treatment of psychosocially stressed male tree shrews with diazepam on locomotor activity, marking behavior, avoidance behavior, and urinary cortisol and noradrenaline. To mimic a realistic situation of anxiolytic intervention, the treatment started 14 days after the beginning of psychosocial stress; at that time, the stress-induced behavioral and endocrine alterations had been established. The drug (5 mg/kg/day) was admin…

MaleClomipraminemedicine.medical_specialtyHypothalamo-Hypophyseal Systemmedicine.drug_classClinical BiochemistryTricyclic antidepressantPituitary-Adrenal SystemMotor ActivityToxicologyBiochemistryAnxiolyticBehavioral NeuroscienceInternal medicinemedicineAvoidance LearningEndocrine systemAnimalsBiological PsychiatryHydrocortisonePharmacologyDiazepamBehavior AnimalTemazepamBody WeightTupaiidaeEndocrinologyOxazepamAnti-Anxiety AgentsPsychologyDiazepamStress Psychologicalmedicine.drugPharmacology, biochemistry, and behavior
researchProduct

Burnout, associated comorbidities and coping strategies in French community pharmacies—BOP study: A nationwide cross-sectional study

2016

International audience; Background: work-related stress and burnout syndromes are unfortunately common comorbidities found in health professionals. However, burnout syndrome has only been partly and episodically assessed for community pharmacists whereas these professionals are exposed to patients’ demands and difficulties every day. Prevalence of burnout, associated comorbidities and coping strategies were assessed in pharmacy teams (pharmacists and pharmacy technicians) in French community pharmacies.Methods: This online survey was performed by emails sent to all French community pharmacies over 3 months. The survey assessed the prevalence of burnout (Maslach Burnout Inventory—MBI—questio…

MaleCoping (psychology)Cross-sectional studyhealth care facilities manpower and services[SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthEmotionsPharmacy TechniciansSocial Scienceslcsh:MedicineAlcohol abuseComorbidityAnxietyBurnoutPharmacists030226 pharmacology & pharmacy0302 clinical medicineSurveys and QuestionnairesAdaptation PsychologicalPrevalenceMedicine and Health SciencesPsychologyAlcohol consumption030212 general & internal medicinelcsh:ScienceBurnout ProfessionalMultidisciplinaryDepressionMiddle AgedPharmacologic stress testingSports Science3. Good healthProfessionsWorkforceWorkforceAnxietyFemaleFrancemedicine.symptompsychological phenomena and processesResearch ArticleAdultmedicine.medical_specialtyAlcohol DrinkingeducationPharmacy03 medical and health scienceshealth services administrationMental Health and PsychiatrymedicineHumansNutritionPharmaciesPharmacologyMood Disordersbusiness.industrylcsh:RBiology and Life SciencesTechniciansmedicine.diseaseComorbidityDietPharmacologic-Based DiagnosticsCross-Sectional StudiesPsychological stress[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthFamily medicinePeople and PlacesPopulation Groupingslcsh:Q[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieSports and exercise medicinebusinessStress PsychologicalAnxiolyticsPLOS ONE
researchProduct

Effects of bupropion, alone or coadministered with nicotine, on social behavior in mice

2008

Bupropion, administered alone or combined with nicotine, is presently used to treat nicotine dependence. Despite experimental evidence of the complex behavioral actions of this drug, there have been little data reported about its effects on social behavior. Our main aim was to investigate the effects of acute administration of bupropion, alone or plus nicotine, on social interaction in mice. OF1 group-housed male mice were confronted in a neutral cage with an anosmic opponent during a 10 minutes encounter. Time allocated to body care and digging was reduced by administration of bupropion (40 mg/kg) both when administered alone and with nicotine (1 and 0.5 mg/kg). The lowest dose of bupropio…

MaleDrugNicotinemedicine.drug_classmedia_common.quotation_subjectMedicine (miscellaneous)Male miceAnxietyPharmacologyAnxiolyticDrug Administration ScheduleNicotineMiceDopamine Uptake Inhibitorsmental disordersmedicineAnimalsSocial BehaviorNicotine dependenceBupropionmedia_commonPharmacologyBupropionBehavior AnimalLow doseTobacco Use Disordermedicine.diseaseGanglionic StimulantsAggressionPsychiatry and Mental healthExploratory BehaviorPsychologymedicine.drugAddiction Biology
researchProduct

Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: Role of CB1 receptors

2013

Numerous reports have highlighted the role of the endocannabinoid system in the addictive potential of MDMA (3,4-methylenedioxy-methamphetamine). A previous report showed that CB1 knockout (KOCB1) mice do not acquire MDMA self-administration, despite developing conditioned place preference (CPP). This contradiction could be due to the particular procedure of place conditioning used. The present work compares MDMA-induced CPP in KOCB1 mice using unbiased and biased procedures of place conditioning. In the unbiased procedure, MDMA induced CPP and reinstatement of the extinguished preference in wild type (WT) mice, but not in KOCB1 mice. In contrast, in a biased protocol of CPP, MDMA produced …

MaleElevated plus mazeTime FactorsSubstance-Related Disordersmedicine.drug_classDopamineN-Methyl-34-methylenedioxyamphetamineNucleus accumbensPharmacologyAnxiolyticDevelopmental psychologyMiceNeurochemicalReceptor Cannabinoid CB1mental disordersmedicineAnimalsMaze LearningBiological PsychiatryMice KnockoutPharmacologyAnalysis of VarianceDose-Response Relationship DrugBrainHomovanillic AcidMDMAConditioned place preferenceDisease Models AnimalMonoamine neurotransmitternervous systemHallucinogens34-Dihydroxyphenylacetic AcidConditioning OperantSerotoninPsychologyReinforcement Psychologypsychological phenomena and processesmedicine.drugProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Effects of co-administration of bupropion and nicotinic agonists on the elevated plus-maze test in mice

2005

There is evidence that the cholinergic nicotinic system is involved in the modulation of anxiety. Anxiolytic and anxiogenic effects of nicotine agonists have been reported in mice. Bupropion is an antidepressant drug which may alleviate some symptoms of nicotine withdrawal, although its effects on anxiety are not clear. It has been suggested that the interaction between bupropion and nicotinic mechanisms could be complex. The aim of the present study was to investigate acute effects of co-administration of bupropion and nicotinic agonists on the elevated plus-maze test in NMRI mice. Effects of nicotine, lobeline, and cytisine (0.35 and 0.175 mg/kg), administered alone or combined with bupro…

MaleElevated plus mazemedicine.drug_classPharmacologyAnxiolyticNicotineMicechemistry.chemical_compoundDopamine Uptake Inhibitorsmental disordersmedicineAnimalsLobelineNicotinic AgonistsMaze LearningBupropionBiological PsychiatryPharmacologyBupropionAnalysis of VarianceBehavior AnimalDose-Response Relationship Drugbusiness.industrymedicine.diseaseDrug CombinationsNicotinic agonistNicotine withdrawalchemistryAnxiogenicbusinesspsychological phenomena and processesmedicine.drugProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct